| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $283.5M | -2.0% |
| Cost of Revenue | $176.3M | -4.6% |
| Gross Profit | $107.2M | +2.6% |
| R&D Expense | $48.8M | +17.8% |
| SG&A Expense | $88.1M | -1.0% |
| Operating Income | -$73.9M | +62.2% |
| Pre-tax Income | -$52.0M | +70.2% |
| Income Tax | -$8.1M | -805.0% |
| Net Income | -$42.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.1M | -43.4% |
| Accounts Receivable | $69.0M | +35.0% |
| Current Assets | $353.6M | -30.4% |
| Total Assets | $1.22B | -1.2% |
| Current Liabilities | $72.9M | -0.2% |
| Total Liabilities | $90.8M | -11.0% |
| Stockholders' Equity | $1.13B | -0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.1M | -22.0% |
| Capital Expenditures | $40.3M | +81.5% |
| Investing Cash Flow | -$58.4M | -250.0% |
| Financing Cash Flow | -$4.8M | +89.9% |
| Free Cash Flow | -$19.3M | -501.5% |
| +74.6% |